CPIX (Cumberland Pharmaceuticals Inc.) Future Price to Earnings

Official company branding of Cumberland Pharmaceuticals Inc. (CPIX)

Stable demand for hospital emergency care products creates a reliable cash flow, and analyzing the estimated forward P/E of Cumberland Pharmaceuticals (CPIX) in GURU.Markets, we note that the metric value is 0.00. The business's resilience is based on the ownership of rare antidotes for resuscitation. However, a limited product range makes the financial result sensitive to the expansion of low-cost generics and the expiration of patents.

cumberlandpharma.com - CPIX Market Cap to Future Earnings Ratio (period 07/04/2022 - 11/16/2026)

Summary analytical data breakdowns for cumberlandpharma.com (CPIX)

- current price and projected stock value:
Fundamental valuation:Cumberland Corp
Brand item of Cumberland Pharmaceuticals

The forward P/E reflects the ratio of the current share price to expected earnings, allowing for the determination of the asset's overvaluation relative to its future cash flows. By analyzing the dynamics of the forward price-to-earnings multiple for Cumberland Pharmaceuticals (CPIX), an investor can identify the fundamental price floor, assessing the growth potential of Cumberland Pharmaceuticals (CPIX) through the introduction of new injectable drug formulations within the saturated US hospital therapy market.

Competitors of Cumberland Pharmaceuticals

Future Price to Earnings haleon.com (HLN)|KVUE (Kenvue Health) - Future Price to Earnings Multiple|Future Price to Earnings Verona Pharma PLC VRNA|Jyong Biotech (MENS) - Projected Price to Earnings Ratio|LGND: Projected Price to Earnings|Amneal - Market Cap to Future Earnings Ratio|PRGO: Forward P/E Multiple|Alvotech Corp - Future Price to Earnings Multiple|LQDA (Liquidia Corp) - Forward P/E Multiple|Projected Price to Earnings Ratio glpg.com GLPG|Future Price to Earnings ANI Pharmaceuticals, Inc. (ANIP)|MNKD (MannKind Corp) - Future Price to Earnings Multiple|Forward P/E Multiple AMPH (Amphastar Pharmaceuticals Inc)|PCRX (Pacira) - Price to Expected Earnings Ratio|SPRY - Future Price to Earnings|Future Price to Earnings Multiple TBPH (Theravance Biopharma)|AQST (aquestive.com) - Projected Price to Earnings|Price to Expected Earnings Ratio SCPH (scPharmaceuticals, Inc.)|Projected Price to Earnings TECX|Tonix Pharmaceuticals (TNXP) - Market Cap to Projected Earnings|Forward P/E Multiple SXTC|Forward P/E Multiple Eupraxia Pharma (EPRX)|Future Price to Earnings BioHarvest Sciences Inc. BHST|EXOZ - Projected Price to Earnings|ORMP: Projected Price to Earnings|Future Price to Earnings Multiple ENTX (enterabio.com)|MindWalk Therapeutics (HYFT) - Future Price to Earnings|Projected Price to Earnings Ratio abvcpharma.com (ABVC)|QNTM (Quantum BioPharma) - Forward P/E Multiple|FGEN: Future Price to Earnings Multiple|Forward P/E Multiple TELO|Forward P/E Multiple Rani Therapeutics Holdings (RANI)|Forward P/E Multiple SNYR (Synergy CHC Corp)|Rallybio Corporation (RLYB) - Projected Price to Earnings Ratio|LEXX - Future Price to Earnings|PULM (Pulmatrix) - Price to Future Earnings Ratio|Pheton Holdings Ltd (PTHL) - Future Price to Earnings|Aptorum - Future Price to Earnings Multiple|Projected Price to Earnings LYRA|Projected Price to Earnings Impact BioMedical Inc (IBO)|Forward P/E Multiple TNFA|YCBD: Price to Expected Earnings Ratio|Future Price to Earnings PainReform PRFX|altamiratherapeutics.com (CYTO) - Projected Price to Earnings Ratio|LIPO: Projected Price to Earnings|OPTN (optinose.com) - Price to Future Earnings Ratio|PIRS: Forward P/E Multiple|PROC - Market Cap to Projected Earnings|PTPI (Petros Pharma) - Forward P/E Multiple|Future Price to Earnings QLI|Forward P/E Multiple SLRN|Market Cap to Future Earnings Ratio TFFP